Nexstim Receives an NBS System Order from a University Hospital in Germany
29 juil. 2021 03h00 HE
|
Nexstim Oyj
Press release, Helsinki, 29 July 2021 at 10 AM (EEST) Nexstim Receives an NBS System Order from a University Hospital in Germany Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces...
Nexstim Receives an NBS System Upgrade Order from a University Hospital in Finland
16 juil. 2021 02h00 HE
|
Nexstim Oyj
Press Release, Helsinki, 16 July 2021 at 9:00 PM (EEST) Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces that it has received a new NBS System upgrade order from a university...
Nexstim Continues to Report Very Promising MDD Treatment Outcomes with Remission Rate Greater than 50%
21 juin 2021 03h30 HE
|
Nexstim Oyj
Press Release, Helsinki, June 21, 2021 at 10:30 AM (EEST) Nexstim Continues to Report Very Promising MDD Treatment Outcomes with Remission Rate Greater than 50% Nexstim Plc (NXTMH:HEX, NXTMS:STO)...
Nexstim Receives an NBS System Order from Australia
19 mai 2021 05h00 HE
|
Nexstim Oyj
Press release, Helsinki, 19 May 2021 at 12 PM (EEST) Nexstim Receives an NBS System Order from Australia Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company”) announces having received a...
Nexstim granted authorization for commercial distribution of NBS system in Australia
18 mai 2021 03h00 HE
|
Nexstim Oyj
Press release, Helsinki, 18 May 2021 at 10 AM (EEST) Nexstim granted authorization for commercial distribution of NBS system in Australia Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company”)...
Impressive New Study Results Suggest Potential New Therapeutic Use for Nexstim SmartFocus® nTMS in Postsurgical Rehabilitation of Paresis
17 mai 2021 03h30 HE
|
Nexstim Oyj
Press release, Helsinki, 17 May 2021 at 10:30 AM (EEST) Impressive New Study Results Suggest Potential New Therapeutic Use for Nexstim SmartFocus® nTMS in Postsurgical Rehabilitation of Paresis ...
Nexstim Receives a New NBS System Order from a Leading California Based Academic Hospital
07 mai 2021 03h00 HE
|
Nexstim Oyj
Press release, Helsinki, 7.5.2021 at 10:00 AM (EEST) Nexstim Receives a New NBS System Order from a Leading California Based Academic Hospital Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or...
Using Rapid-Acting Brain Stimulation for Treatment-Resistant Depression - A Free Webinar from the Brain & Behavior Research Foundation
04 mai 2021 09h00 HE
|
Brain & Behavior Research Foundation
New York, May 04, 2021 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “Using Rapid-Acting Brain Stimulation for Treatment-Resistant Depression” on...
Nexstim Receives Positive Feedback from Mind Matters Psychiatry MD on Use of Their Two NBT® Systems to Treat MDD
16 avr. 2021 05h00 HE
|
Nexstim Oyj
Press release, Helsinki, 16.04.2021, 12.00 pm (EEST) Nexstim Receives Positive Feedback from Mind Matters Psychiatry MD on Use of Their Two NBT® Systems to Treat MDD Nexstim Plc (NXTMH:HEX,...
Nexstim Gives an Update on its Promising Treatment Results of Major Depressive Disorder
12 mars 2021 03h00 HE
|
Nexstim Oyj
Press Release, Helsinki, 12 March 2021 at 10.00 (EET) Nexstim Gives an Update on its Promising Treatment Results of Major Depressive Disorder Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or...